Research into rare diseases is providing insights into the future of precision medicine. The use of technologies such as artificial intelligence is being explored to accelerate drug development and improve clinical trials for these conditions. However, the progress of this research may be impacted by funding decisions, with some reports indicating a retreat in US research funding, while others highlight recent funding announcements and breakthroughs in treatment development.